Acino
SwitzerlandWho owns Acino?
Acino is a Swiss Pharma company, now owned by ADQ, which acquired it in 2022 from Ardian.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2022 to ADQ.
- ·Average hold across 2 realized cycles: 7 years.
Ownership history
2 ownership periods · co-invest detected
Ardian sold Acino to ADQ in 2022 after 9 years.
Nordic Capital sold Acino to Arab Investors-TA consortium in 2017 after 4 years.
More from Nordic Capital Fund VIII
Other portfolio companies in the same fund.
Germany
Sweden
DenmarkMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
France
SpainQuestions
Who owns Acino?
Acino is now owned by ADQ, which acquired it in 2022 from Ardian.
When did ADQ acquire Acino?
ADQ acquired Acino in 2022, buying from Ardian.
Who did Acino sell to?
Ardian sold Acino to ADQ in 2022 (Secondary). Nordic Capital sold Acino to Arab Investors-TA consortium in 2017 (Trade Sale).
Who has owned Acino over time?
Acino has been through 2 private-equity ownership periods: Ardian · via Ardian Co-Investment Fund III · 2013–2022 · sold to ADQ · (Secondary); Nordic Capital · via Nordic Capital Fund VIII · 2013–2017 · sold to Arab Investors-TA consortium · (Trade Sale).